Taylor Wessing advises Rutland Partners on €180M Sale of Attends Healthcare

International law firm Taylor Wessing has advised Rutland Partners, the specialist turnaround and restructuring investor, on the conditional sale of Attends Healthcare Group to Domtar Corporation for an enterprise value of €180 million.

Attends is a European leader in the manufacture and supply of branded and own label adult incontinence products.

Nick Hazell, partner in the Private Equity group, who lead the Taylor Wessing team advising Rutland Partners, commented:

“We acted on Rutland’s original secondary buy out from 3i in 2007 and it’s great to see the results of their extensive operational restructuring reflected in this deal.  It’s also illustrative of a trend we’ve been seeing for a while of international corporates with strong balance sheets competing favourably for European assets.  ”

Oliver Jones of Rutland Partners commented:

“We are grateful to Nick and his team for the outstanding support they provided on this deal. Access to specialist input was particularly useful for certain aspects of this transaction, and we were impressed by the depth and quality of advice that TW provided.”

The Taylor Wessing team drawn from across the firm also included Brian McCloskey, Dan Perkins and Amy Adair (Corporate), Martin Yells (Finance), Robert Young (Tax), Tim Worden and Colin McCall (IP/Patents), Louisa Penny (Competition), Louise Howard (Pensions) and Anna Humphrey (Employee Incentives)

The transaction is conditional only on customary regulatory clearances and is expected to complete in late February. 

Lawyers Nicholas Hazell, Brian McCloskey, Martin Yells, Robert Young, Tim Worden, Colin McCall, Louisa Penny, Louise Howard, Anna Humphrey